-
1
-
-
0026508582
-
Metastatic bone disease: Clinical and therapeutic aspects
-
Body JJ. Metastatic bone disease: clinical and therapeutic aspects. Bone 1992; 13: S57-62.
-
(1992)
Bone
, vol.13
-
-
Body, J.J.1
-
3
-
-
0036675220
-
Metastasis to bone: Causes, consequences and therapeutic opportunities
-
Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002; 2: 584-93.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 584-593
-
-
Mundy, G.R.1
-
4
-
-
0036039366
-
The role of bisphosphonates in breast cancer management
-
Pickering LM, Mansi JL. The role of bisphosphonates in breast cancer management. Curr Med Res Opin 2002; 18: 284-95.
-
(2002)
Curr Med Res Opin
, vol.18
, pp. 284-295
-
-
Pickering, L.M.1
Mansi, J.L.2
-
5
-
-
0042887042
-
The emerging role of lysophosphatidic acid in cancer
-
Mills GB, Moolenaar WH. The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 2003; 3: 582-91.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 582-591
-
-
Mills, G.B.1
Moolenaar, W.H.2
-
6
-
-
15244343497
-
Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer
-
Boucharaba A, Serre CM, Gres S, et al. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Invest 2004; 114: 1714-25.
-
(2004)
J Clin Invest
, vol.114
, pp. 1714-1725
-
-
Boucharaba, A.1
Serre, C.M.2
Gres, S.3
-
7
-
-
0242412965
-
Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity
-
Peyruchaud O, Serre CM, NicAmhlaoibh R, et al. Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity. J Biol Chem 2003; 278: 45 826-32.
-
(2003)
J Biol Chem
, vol.278
-
-
Peyruchaud, O.1
Serre, C.M.2
NicAmhlaoibh, R.3
-
8
-
-
1542359873
-
Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
-
Umezu-Goto M, Kishi Y, Taira A, et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 2002; 158: 227-33.
-
(2002)
J Cell Biol
, vol.158
, pp. 227-233
-
-
Umezu-Goto, M.1
Kishi, Y.2
Taira, A.3
-
9
-
-
0027232391
-
The bioactive phospholipid lysophosphatidic acid is released from activated platelets
-
Eichholtz T, Jalink K, Fahrenfort I, Moolenaar WH. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 1993; 291: 677-80.
-
(1993)
Biochem J
, vol.291
, pp. 677-680
-
-
Eichholtz, T.1
Jalink, K.2
Fahrenfort, I.3
Moolenaar, W.H.4
-
10
-
-
0015784395
-
Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease
-
Gasic GJ, Gasic TB, Galanti N, et al. Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer 1973; 11: 704-18.
-
(1973)
Int J Cancer
, vol.11
, pp. 704-718
-
-
Gasic, G.J.1
Gasic, T.B.2
Galanti, N.3
-
11
-
-
0036676419
-
Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone
-
Pecheur I, Peyruchaud O, Serre CM, et al. Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone. FASEB J 2002; 16: 1266-8.
-
(2002)
FASEB J
, vol.16
, pp. 1266-1268
-
-
Pecheur, I.1
Peyruchaud, O.2
Serre, C.M.3
|